Literature DB >> 33630031

JAK inhibition for treatment of psoriatic arthritis in Down syndrome.

Andrew T Pham1, Angela L Rachubinski1,2, Belinda Enriquez-Estrada1, Kayleigh Worek1, Melissa Griffith3, Joaquin M Espinosa1,4.   

Abstract

Entities:  

Year:  2021        PMID： 33630031     DOI： 10.1093/rheumatology/keab203

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

Review 1.  Down Syndrome-Associated Arthritis (DA): Diagnostic and Management Challenges.

Authors:  Jordan T Jones; Jacqueline Kitchen; Nasreen Talib
Journal:  Pediatric Health Med Ther       Date:  2022-03-14

2.  Treatment of Down Syndrome-Associated Arthritis with JAK Inhibition.

Authors:  Jordan T Jones
Journal:  Case Rep Rheumatol       Date:  2022-07-16

Review 3.  Down syndrome and type I interferon: not so simple.

Authors:  Louise Malle; Dusan Bogunovic
Journal:  Curr Opin Immunol       Date:  2021-06-23       Impact factor: 7.268
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.